Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Scottish pharmacies to receive £2.6m funding increase for 2018-19

Funding for Scottish pharmacies will increase by £2.6 million for 2018-19, Community Pharmacy Scotland (CPS) has announced.

Under the latest funding settlement, the global sum will increase to £180.96m, CPS confirmed this afternoon (June 15).

The increase follows two years where the global sum has stood at £178.4m.

The latest settlement “will continue the process of developing our contractual arrangements to reflect funding alongside appropriate service provision to the Scottish population”, CPS said.

The "non-global sum" – which is dependent on factors such as margins – will remain unchanged from its current level of £1.3m, CPS confirmed.

Clawback rate rise

The generic clawback rate will rise from 0% to 1.5% to reflect the £5m accumulated in 2017-18, CPS added.

The Scottish government stressed that this rate will be “temporarily suspended or adjusted” should the “market deteriorate…to ensure sufficient cash liquidity to the pharmacy network”.

The clawback rate would then be reintroduced once market conditions recover, the government added.

CPS director of operations Matt Barclay told C+D the ability to “switch off” the clawback mechanism “will allow cash to flow to contractors should the market be impacted”.

No conflict in negotiations

Funding negotiations between CPS and the government had been “constructive” and “at no time was there conflict”, he told C+D.

What do you make of the funding settlement?

Related Content


Pharmacy Assistant
Paignton, Devon
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts